Breaking News, Promotions & Moves

Amgen Appoints SVP of Research and Chief Scientific Officer

Howard Chang will establish and lead research priorities in Amgen's rare disease, oncology, inflammation, and cardiometabolic areas.

Author Image

By: Charlie Sternberg

Associate Editor

Amgen has welcomed Howard Chang, M.D., Ph.D. to the company as senior vice president of Research, effective Dec. 16, 2024. Chang will also assume the title and responsibility of serving as Amgen’s chief scientific officer, reporting to Jay Bradner, M.D., executive vice president of Research and Development.   “Howard is one of our generation’s foremost physician-scientists, with expertise in human genetics and a profound ability to distill complex disease biology into clarifi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters